https://www.selleckchem.com/pr....oducts/vorolanib.htm
113; 95% CI 0.674-1.837). We noted a potential toward greater complete ST-segment resolution in RIC patients compared with IPC patients (odds ratio (OR) = 0.821; 95% CI 0.166-4.051). No significant difference existed in all-cause mortality (OR = 2.211; 95% CI 0.845-5.784), Target vessel revascularization (TVR) (OR = 0.045; 95% CI 0.001-.662) or re-infarction (OR = 1.763; 95% CI 0.741-4.193). This meta-analysis suggested RIC was correlated with significantly smaller infarction size compared to IPC. No significant superiority between RI